MetLife Investment Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $185K | Buy |
76,687
+29,933
| +64% | +$72.1K | ﹤0.01% | 2237 |
|
|
2025
Q1 | $103K | Sell |
46,754
-28,150
| -38% | -$62.2K | ﹤0.01% | 2512 |
|
|
2024
Q4 | $408K | Buy |
74,904
+10,168
| +16% | +$55.4K | ﹤0.01% | 1909 |
|
|
2024
Q3 | $538K | Buy |
64,736
+36,476
| +129% | +$303K | ﹤0.01% | 1746 |
|
|
2024
Q2 | $202K | Buy |
28,260
+23,491
| +493% | +$168K | ﹤0.01% | 2238 |
|
|
2024
Q1 | $41.3K | Buy |
4,769
+14
| +0.3% | +$121 | ﹤0.01% | 2733 |
|
|
2023
Q4 | $31.1K | Sell |
4,755
-70
| -1% | -$458 | ﹤0.01% | 2796 |
|
|
2023
Q3 | $48.3K | Buy |
4,825
+3
| +0.1% | +$30 | ﹤0.01% | 2836 |
|
|
2023
Q2 | $59.9K | Sell |
4,822
-1,831
| -28% | -$22.8K | ﹤0.01% | 2880 |
|
|
2023
Q1 | $93.2K | Buy |
6,653
+15
| +0.2% | +$210 | ﹤0.01% | 2580 |
|
|
2022
Q4 | $95K | Sell |
6,638
-174
| -3% | -$2.49K | ﹤0.01% | 2615 |
|
|
2022
Q3 | $174K | Buy |
6,812
+5
| +0.1% | +$128 | ﹤0.01% | 2391 |
|
|
2022
Q2 | $193K | Sell |
6,807
-294
| -4% | -$8.35K | ﹤0.01% | 2345 |
|
|
2022
Q1 | $250K | Buy |
+7,101
| New | +$250K | ﹤0.01% | 2216 |
|